Live Immunotherapy updates | Page 11

Live Immunotherapy news coverage of developments with the latest updates. Stay on top of latest Immunotherapy news stories and find out what just happened, what is going on with Immunotherapy. The latest real-time news updates and headlines on Immunotherapy
Cancer Neuroscience: New Oncology Branch Targets Tough Brain Tumors
Wistar Engineers New Therapy Targeting Stubborn Ovarian Cancer
NIH Develops Method to Boost T-Cell Therapies for Tumors
Multi-million dollar boost into child research programs
Dom's Finding strength in being open about cancer
Potential Achilles' Heel for Triple-Negative Breast Cancer: Protein eIF4A
Zanubrutinib Offers Added Benefit for Specific Leukemia Patients
Novel Antibody Method Targets Hidden Cancer Mutations
New Insights on Prostate Cancer Disparities Unveiled
Queensland Breast Cancer Patients Find Hope in Clinical Trials
New Biomarker Revolutionizes Targeted Cancer Treatments
UH Researchers Discover Liver Cancer Treatment Resistance
ERC Synergy Grant for Immunotherapy of Liver Metastases
Machine Speeds Up Cell Production for Cancer Treatment
Innovative Study Targets Enhanced Wound Healing, Cancer Therapy
Cancer's sweet Achilles heel
Emory Neurosurgeon Granted $1.96M NIH Fund for Glioblastoma Study
Breakthrough T Cell Discovery Boosts Custom Immune Engineering
Biden Speaks at National Science and Technology Medal Event
UQ research backed by Australian Economic Accelerator
Epigenetic Drugs May Boost Cancer Immunotherapy
NSF Applauds Recipients of National Medals of Science & Tech
NIH's Steven Rosenberg Receives Top US Tech Innovation Honor
UConn Nurse Overcomes Breast Cancer, Urges Mammograms
NIH Funds Rutgers to Probe Infection Impact on Lung Disease Immunity
Rutgers Gets $3.9M to Examine Infection Impact on Lung Disease Immunity
Immutep's Efti Proves Effective Combined with MSD's Pembrolizumab
Switch to Trigger Cancer Cell Death Discovered by Researchers
Switch to Trigger Cancer Cell Death Identified by Researchers
Over 50% Major Response to Pembrolizumab in Melanoma Trial
Pre/Post-Surgery Immunotherapy Boosts Lung Cancer Outcomes
EU Approves Enhertu, First HER2-Directed Therapy for Advanced NSCLC
Immunotherapy Boosts Survival in Metastatic Bladder Cancer
ESMO: Erdafitinib Boosts Response in Advanced Urinary Cancers
Datopotamab Deruxtecan, Imfinzi Show Strong Results in BEGONIA Trial
ESMO: Immunotherapy Boosts Operable Lung Cancer Surgery Outcomes
ESMO: Immunotherapy Boosts Operable Lung Cancer Surgery Results
Belzutifan Outperforms Everolimus in Advanced Kidney Cancer Study
Advanced Kidney Cancer Patients See Improved Results with Belzutifan
Imfinzi and Lynparza Cut Advanced Endometrial Cancer Risk by 45%
ESMO Manifesto Converts Scientific Evidence into Public Health Policy
INKT Cell Platform Shows Potential in Cancer Treatment Study
Imfinzi Boosts Response Rate in Early-Stage Stomach Cancers
Alice Springs Hospital Boosts Oncology, Cardiology Services
Special Edition: ESMO 2023 Key Findings from MD Anderson
MRNA Induces Immunotherapy Response in Glioblastoma
New Drug Mechanism Paves Way for Anti-Cancer Immunotherapies
Dual-Target Cancer Drug Shows Promise in Early Trial